Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis | Zendy

Ritesh Agarwal | Zendy; Ajmal Khan | Zendy; Ashutosh N. Aggarwal | Zendy; Deepak Gupta | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis

Author(s) -

Ritesh Agarwal,

Ajmal Khan,

Ashutosh N. Aggarwal,

Deepak Gupta

Publication year - 2016

Publication title -

monaldi archives for chest disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.196

H-Index - 46

eISSN - 2465-101X

pISSN - 1122-0643

DOI - 10.4081/monaldi.2009.348

Subject(s) - asthma , meta analysis , asthma exacerbations , medicine , intensive care medicine

The combination of inhaled corticosteroids (ICS) and long-acting beta2 agonists (LABA) has been used as a single inhaler both for maintenance and reliever therapy in asthma, the SMART approach. The administration of additional CS with each reliever inhalation in response to symptoms is expected to provide better control of airway inflammation. The aim of this meta-analysis was to evaluate the efficacy and safety of the SMART approach versus other approaches in the management of asthma in preventing asthma exacerbations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research